Patents for A61K 49 - Preparations for testing in vivo (35,376)
08/2004
08/19/2004WO2004069284A2 Ultrasound contrast agents and process for the preparation thereof
08/19/2004WO2004069283A1 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection
08/19/2004WO2004069281A1 Bifunctional molecules comprising at least one integrin-binding and their use in imaging and therapy of angiogenesis and related disorders
08/19/2004WO2004069269A1 Method for making a cell more susceptible for a compound by expressing the protein, on which said compound acts, in said cell
08/19/2004WO2004069193A2 Methods and compositions for inhibiting cholesterol uptake
08/19/2004WO2004069179A2 Improved thickened beverages for dysphagia
08/19/2004WO2004069169A2 Localized drug delivery using drug-loaded nanocapsules and implantable device coated with the same
08/19/2004WO2004069153A2 Apparatus, system and method for generating bubbles on demand
08/19/2004WO2004042353A3 Identifying therapeutic compounds based on their physical-chemical properties
08/19/2004WO2003068919A3 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/19/2004WO2003038123A3 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene
08/19/2004WO2003006625A8 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
08/19/2004US20040162243 Compositions of S-nitrosothiols and methods of use
08/19/2004US20040161815 in amidation of folded polypeptides and proteins based on the use of a chemical structure element comprising an imidazole function; solid phase synthesis
08/19/2004US20040161451 Soft filament occlusive device delivery system
08/19/2004US20040161384 Ultrasound contrast agents; dissolving subliming, water insoluble substance then polymer in nonpolar solvent; emulsifying, adding surfactant and hardening; reproducible size
08/19/2004US20040161383 Diagnostic agents for pancreatic exocrine function
08/19/2004CA2694872A1 Improved thickened beverages for dysphagia
08/19/2004CA2514307A1 Improved radiometal complex compositions
08/18/2004CN1162186C Low-density gastrointestinal contrast medium and its production process
08/17/2004US6776977 Polypodal chelants for metallopharmaceuticals
08/17/2004US6776761 Introducing contrast agent of microbubbles having constant wall thickness to diameter ratio and threshold intensity of ultrasonic power of microbubble rupture within power range useful for diagnostic imaging, applying ultrasonic signal
08/12/2004WO2004068405A2 High contrast optoacoustical imaging using nanoparticles
08/12/2004WO2004067483A2 Chelating agents with lipophilic carriers
08/12/2004WO2004066995A1 Method for treating ischemic stroke with melatonin
08/12/2004WO2003015606A3 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
08/12/2004US20040157953 Materials for filling cavities in the body
08/12/2004US20040157951 Monodisperse preparations useful with implanted devices
08/12/2004US20040157905 Administering protoporhyrin ix ; detection accumulation in cells; measurement cell proliferation
08/12/2004US20040156899 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
08/12/2004US20040156786 Paramagnetic complexes as contrast agents for magnetic resonance imaging; chelate compounds
08/12/2004US20040156785 Magnetic resonance or optical imaging prodrug contrast agent having lower affinity for tissue protein than bioactivated form
08/12/2004US20040156784 Paramagnetic nanoparticle
08/12/2004US20040156783 Complexes of cyanine, indocyanine, phthalocyanine, rhodamine, oxazine, thiazine, phenoselenazines, fluoresceins, porphyrin, squaraine, corrins, croconium, azo, methine and/or indolenium dye linked with receptor binding molecules; tumors
08/12/2004US20040156782 Methods of using indocyanine green (ICG) dye
08/12/2004US20040156781 Polymeric materials for site specific delivery to the body
08/12/2004CA2514201A1 Chelating agents with lipophilic carriers
08/11/2004EP1445622A2 Hyperpolarized gas transport device
08/11/2004EP1444991A1 Novel targeted compositions for diagnostic and therapeutic use
08/11/2004EP1444990A1 Improved Radiometal Complex Compositions
08/11/2004EP1444236A1 Separation of regioisomers of metal phthalocyanines
08/11/2004EP1443972A2 Pathological tissue detection and treatment employing targeted benzoindole optical agents
08/11/2004EP1443963A2 Antibody targeting compounds
08/11/2004EP1443953A2 Detection and treatment of intravascular lesions
08/11/2004EP1443899A2 Bowel cleansing agent
08/11/2004EP1443861A2 Tumor targeted photodiagnostic-phototherapeutic agents
08/11/2004EP1443860A2 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications
08/11/2004EP1131280B1 Preparation of 5-amino-isophthalamides
08/11/2004EP1028991B1 Strictly alternating poly(alkylene oxide ether) copolymers
08/11/2004EP0787017B1 Diagnostic preparation for detection of helicobacter pylori
08/11/2004CN1519041A Method and equipment for setting medical care device of ultrasound microbubble contrast media to form embolism in capillary vessel
08/11/2004CN1161324C Yellow polymorph of 5-amino-2,4,6-triiodo-N,N'-bis(2,3-dihydroxypropyl)-isophthalamide
08/10/2004US6774228 1,4,7,10-tetrazacyclododecanes capable of reacting with monoclonal or polyclonal antibody; imaging
08/10/2004US6773916 Administering sub-immunological sized antigen-binding molecule (fc/fv fragments)
08/10/2004US6773696 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region
08/08/2004CA2619590A1 Solution based methacholine formulations
08/05/2004WO2004065621A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
08/05/2004WO2004065567A2 Brain progenitor cell-based assay, and related methods and compositions
08/05/2004WO2004064869A2 Amyloid-binding, metal-chelating agents
08/05/2004WO2004064768A2 Animal model for alzheimer's disease
08/05/2004WO2004064751A2 Nanoparticle based stabilization of ir fluorescent dyes
08/05/2004WO2004064742A2 Methods and compositions for p2x receptor calcium entry channels and other calcium entry mechanisms
08/05/2004WO2004064740A2 Sperm specific lysozyme-like proteins
08/05/2004WO2004064714A2 Animal model for obesity independently of insulin resistance
08/05/2004WO2004064611A2 Resorbable radiopaque markers and related medical implants
08/05/2004WO2004043513A3 Surface dissolution and/or bulk erosion controlled release compositions and devices
08/05/2004WO2004026100A3 Using magnetic resonance imaging to directly map neuronal activity
08/05/2004WO2003084386A3 Methods for ultrasonic imaging and treating diseased tissues
08/05/2004WO2003045979A3 Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
08/05/2004US20040152157 G-protein coupled receptors
08/05/2004US20040152144 Novel method of diagnosing, monitoring, staging, imaging and treating breast cancer
08/05/2004US20040152143 Growth differentiation factor-9
08/05/2004US20040152068 Ocular diagnosis of Alzheimer's disease
08/05/2004US20040151707 Vascular cells genetically altered to over-express angiogenic proliferation and maturation factors; treatment of atherosclerosis using same
08/05/2004US20040151702 Production and use of a suspension composition comprising an ultrasound contrast medium
08/05/2004US20040151668 Stool marker
08/05/2004US20040151667 Internal image antibodies for optical imaging and therapy
08/05/2004US20040151666 Rodent mammary window for intravital microscopy of orthotopic breast cancer and related method
08/05/2004DE10046465B4 Verwendung von Fluorpropan als Spurengas zur Bestimmung der funktionellen Lungenresidualkapazität Use of fluorine propane as a trace gas for determining the functional Lungenresidualkapazität
08/05/2004CA2516116A1 Nanoparticle based stabilization of ir fluorescent dyes
08/05/2004CA2514200A1 Amyloid-binding, metal-chelating agents
08/05/2004CA2513044A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
08/04/2004EP1442751A1 Method of imaging
08/04/2004EP1442064A2 Kinases and phosphatases
08/04/2004EP1441773A1 Pacap compositions and methods for tumor imaging and therapy
08/04/2004EP1441765A2 Method for preparation of single chain antibodies
08/04/2004EP1313772B1 New cross-linked derivatives of hyaluronic acid
08/04/2004EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives
08/04/2004EP1113823B1 Chiral radio-contrast agents
08/04/2004CN1518479A Stabilization and terminal sterilization of phospholipid formulations
08/03/2004US6772000 Magnetic resonance imaging devices with a contrast medium for improved imaging
08/03/2004US6770787 Heavier halogen atom substituted squaraine based dyes, process for the preparation thereof and use thereof as sensitizers for photodynamic, therapeutical and industrial applications
08/03/2004US6770261 Magnetic resonance imaging agents for the detection of physiological agents
08/03/2004CA2142599C Method for diagnosing and monitoring sepsis
08/03/2004CA2041093C A pharmacological composition containing polyelectrolyte complexes in microparticulate form and at least one active substance
07/2004
07/29/2004WO2004064109A2 Water soluble metal and semiconductor nanoparticle complexes
07/29/2004WO2004063354A2 Compositions and methods for characterizing and regulating wnt pathways
07/29/2004WO2004063200A1 Porphyrin derivatives
07/29/2004WO2004063093A1 Process and system for producing nuclear spin polarized xenon gas
07/29/2004WO2004062627A2 In vivo screening models for treatment of alzheimer's disease and other neurodegenerative disorders